IRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference
IRhythm Technologies Says Zio LTCM Shows 'Highest Diagnostic Yield' Vs Other Devices
IRhythm Presents AVALON Study Results at HRS2025, Showcasing Largest Real-World ACM Analysis
IRhythm Technologies Presents AVALON Study Findings Demonstrating Superiority of Zio LTCM in Commercially Insured Patients at HRS2025
Earnings Preview: IRTC to Report Financial Results Post-market on May 01
The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, IRhythm Technologies and SOPHiA GENETICS
Investors in IRhythm Technologies (NASDAQ:IRTC) Have Unfortunately Lost 23% Over the Last Three Years
IRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025
IRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability
Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer
Truist Financial Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $120
Express News | IRhythm Technologies Inc : Truist Securities Cuts Target Price to $120 From $145
When Will IRhythm Technologies, Inc. (NASDAQ:IRTC) Turn A Profit?
IRhythm Technologies Insiders Sold US$12m Of Shares Suggesting Hesitancy
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
IRhythm Technologies (NASDAQ:IRTC) Is Making Moderate Use Of Debt
Irhythm Technologies Insider Sold Shares Worth $281,671, According to a Recent SEC Filing
BTIG Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $135
Express News | Goldman Sachs Maintains Neutral on IRhythm Technologies, Raises Price Target to $124
IRhythm Technologies Full Year 2024 Earnings: Beats Expectations